• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于机器学习的中国慢性心力衰竭患者心力衰竭恶化风险模型

Machine learning-based model for worsening heart failure risk in Chinese chronic heart failure patients.

作者信息

Sun Ziyi, Wang Zihan, Yun Zhangjun, Sun Xiaoning, Lin Jianguo, Zhang Xiaoxiao, Wang Qingqing, Duan Jinlong, Huang Li, Li Lin, Yao Kuiwu

机构信息

Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.

Graduate School, Beijing University of Chinese Medicine, Beijing, China.

出版信息

ESC Heart Fail. 2025 Feb;12(1):211-228. doi: 10.1002/ehf2.15066. Epub 2024 Sep 7.

DOI:10.1002/ehf2.15066
PMID:39243185
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11769658/
Abstract

AIMS

This study aims to develop and validate an optimal model for predicting worsening heart failure (WHF). Multiple machine learning (ML) algorithms were compared, and the results were interpreted using SHapley Additive exPlanations (SHAP). A clinical risk calculation tool was subsequently developed based on these findings.

METHODS AND RESULTS

This nested case-control study included 200 patients with chronic heart failure (CHF) from the China-Japan Friendship Hospital (September 2019 to December 2022). Sixty-five variables were collected, including basic information, physical and chemical examinations, and quality of life assessments. WHF occurrence within a 3-month follow-up was the outcome event. Variables were screened using LASSO regression, univariate analysis, and comparison of key variables in multiple ML models. Eighty per cent of the data was used for training and 20% for testing. The best models were identified by integrating nine ML algorithms and interpreted using SHAP, and to develop a final risk calculation tool. Among participants, 68 (34.0%) were female, with a mean age (standard deviation, SD) of 68.57 (12.80) years. During the follow-up, 60 participants (30%) developed WHF. N-terminal pro-brain natriuretic peptide (NT-proBNP), creatinine (Cr), uric acid (UA), haemoglobin (Hb), and emotional area score on the Minnesota Heart Failure Quality of Life Questionnaire were critical predictors of WHF occurrence. The random forest (RF) model was the best model to predict WHF with an area under the curve (AUC) (95% confidence interval, CI) of 0.842 (0.675-1.000), accuracy of 0.775, sensitivity of 0.900, specificity of 0.833, negative predictive value of 0.800, and positive predictive value of 0.600 for the test set. SHAP analysis highlighted NT-proBNP, UA, and Cr as significant predictors. An online risk predictor based on the RF model was developed for personalized WHF risk assessment.

CONCLUSIONS

This study identifies NT-proBNP, Cr, UA, Hb, and emotional area scores as crucial predictors of WHF in CHF patients. Among the nine ML algorithms assessed, the RF model showed the highest predictive accuracy. SHAP analysis further emphasized NT-proBNP, UA, and Cr as the most significant predictors. An online risk prediction tool based on the RF model was subsequently developed to enhance early and personalized WHF risk assessment in clinical settings.

摘要

目的

本研究旨在开发并验证一个用于预测心力衰竭恶化(WHF)的最佳模型。比较了多种机器学习(ML)算法,并使用夏普利值附加解释(SHAP)对结果进行解读。随后基于这些发现开发了一种临床风险计算工具。

方法与结果

这项巢式病例对照研究纳入了来自中日友好医院(2019年9月至2022年12月)的200例慢性心力衰竭(CHF)患者。收集了65个变量,包括基本信息、理化检查和生活质量评估。3个月随访期内发生WHF为结局事件。使用套索回归、单因素分析以及多个ML模型中的关键变量比较对变量进行筛选。80%的数据用于训练,20%用于测试。通过整合9种ML算法确定最佳模型,并使用SHAP进行解读,以开发最终的风险计算工具。参与者中,68名(34.0%)为女性,平均年龄(标准差,SD)为68.57(12.80)岁。随访期间,60名参与者(30%)发生了WHF。N末端脑钠肽前体(NT-proBNP)、肌酐(Cr)、尿酸(UA)、血红蛋白(Hb)以及明尼苏达心力衰竭生活质量问卷中的情感领域得分是WHF发生的关键预测因素。随机森林(RF)模型是预测WHF的最佳模型,测试集的曲线下面积(AUC)(95%置信区间,CI)为0.842(0.675 - 1.000),准确率为0.775,敏感性为0.900,特异性为0.833,阴性预测值为0.800,阳性预测值为0.600。SHAP分析突出了NT-proBNP、UA和Cr作为显著预测因素。基于RF模型开发了一个在线风险预测器,用于个性化的WHF风险评估。

结论

本研究确定NT-proBNP、Cr、UA、Hb和情感领域得分是CHF患者发生WHF的关键预测因素。在评估的9种ML算法中,RF模型显示出最高的预测准确性。SHAP分析进一步强调NT-proBNP、UA和Cr是最显著的预测因素。随后开发了一个基于RF模型的在线风险预测工具,以加强临床环境中WHF的早期和个性化风险评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/11769658/99cef386f2e0/EHF2-12-211-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/11769658/0034ec1f1082/EHF2-12-211-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/11769658/304bb5e5b0bb/EHF2-12-211-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/11769658/2d78b6667934/EHF2-12-211-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/11769658/69eeb155275f/EHF2-12-211-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/11769658/b0b7482ddb43/EHF2-12-211-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/11769658/ecae20c7361e/EHF2-12-211-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/11769658/a715a2603a7e/EHF2-12-211-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/11769658/99cef386f2e0/EHF2-12-211-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/11769658/0034ec1f1082/EHF2-12-211-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/11769658/304bb5e5b0bb/EHF2-12-211-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/11769658/2d78b6667934/EHF2-12-211-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/11769658/69eeb155275f/EHF2-12-211-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/11769658/b0b7482ddb43/EHF2-12-211-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/11769658/ecae20c7361e/EHF2-12-211-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/11769658/a715a2603a7e/EHF2-12-211-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/11769658/99cef386f2e0/EHF2-12-211-g007.jpg

相似文献

1
Machine learning-based model for worsening heart failure risk in Chinese chronic heart failure patients.基于机器学习的中国慢性心力衰竭患者心力衰竭恶化风险模型
ESC Heart Fail. 2025 Feb;12(1):211-228. doi: 10.1002/ehf2.15066. Epub 2024 Sep 7.
2
Development of interpretable machine learning models to predict in-hospital prognosis of acute heart failure patients.开发可解释的机器学习模型以预测急性心力衰竭患者的院内预后。
ESC Heart Fail. 2024 Oct;11(5):2798-2812. doi: 10.1002/ehf2.14834. Epub 2024 May 15.
3
Machine learning-based prediction of elevated N terminal pro brain natriuretic peptide among US general population.基于机器学习对美国普通人群中N末端脑钠肽前体升高情况的预测
ESC Heart Fail. 2025 Apr;12(2):859-868. doi: 10.1002/ehf2.15056. Epub 2024 Nov 19.
4
The Importance of Worsening Heart Failure in Ambulatory Patients: Definition, Characteristics, and Effects of Amino-Terminal Pro-B-Type Natriuretic Peptide Guided Therapy.门诊患者心力衰竭恶化的重要性:氨基末端 B 型利钠肽前体指导治疗的定义、特征和影响。
JACC Heart Fail. 2016 Sep;4(9):749-55. doi: 10.1016/j.jchf.2016.03.012. Epub 2016 May 11.
5
The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart failure.N末端B型利钠肽原对中国老年慢性心力衰竭患者的预测能力及额外预后价值
Clin Interv Aging. 2015 Jan 27;10:359-65. doi: 10.2147/CIA.S77417. eCollection 2015.
6
A prediction model for estimating NT-proBNP in a general Japanese population: the Toon Health Study.一个用于估算日本一般人群中 NT-proBNP 的预测模型:Toon 健康研究。
ESC Heart Fail. 2024 Jun;11(3):1483-1492. doi: 10.1002/ehf2.14691. Epub 2024 Feb 1.
7
Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score.N末端B型利钠肽原在急性失代偿性心力衰竭患者风险分层中的临床应用。急性失代偿性心力衰竭/NT-proBNP风险评分的推导与验证。
Int J Cardiol. 2013 Oct 3;168(3):2120-6. doi: 10.1016/j.ijcard.2013.01.005. Epub 2013 Feb 6.
8
Diagnosis of chronic heart failure by the soluble suppression of tumorigenicity 2 and N-terminal pro-brain natriuretic peptide.通过可溶性肿瘤生长抑制因子2和N末端B型利钠肽原诊断慢性心力衰竭
J Clin Lab Anal. 2018 Mar;32(3). doi: 10.1002/jcla.22295. Epub 2017 Jul 18.
9
[Constructing a predictive model for the death risk of patients with septic shock based on supervised machine learning algorithms].基于监督机器学习算法构建脓毒症休克患者死亡风险预测模型
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024 Apr;36(4):345-352. doi: 10.3760/cma.j.cn121430-20230930-00832.
10
The minimal informative monitoring interval of N-terminal pro-B-type natriuretic peptide in patients with stable heart failure.稳定型心力衰竭患者 N 端脑利钠肽前体的最小信息量监测间隔。
BMC Cardiovasc Disord. 2020 Jun 1;20(1):262. doi: 10.1186/s12872-020-01537-7.

本文引用的文献

1
Machine learning based readmission and mortality prediction in heart failure patients.基于机器学习的心力衰竭患者再入院和死亡率预测。
Sci Rep. 2023 Oct 31;13(1):18671. doi: 10.1038/s41598-023-45925-3.
2
Developing Clinical Risk Prediction Models for Worsening Heart Failure Events and Death by Left Ventricular Ejection Fraction.基于左心室射血分数开发心力衰竭恶化事件和死亡的临床风险预测模型。
J Am Heart Assoc. 2023 Oct 3;12(19):e029736. doi: 10.1161/JAHA.122.029736. Epub 2023 Sep 30.
3
Prevalence of heart failure stages in the general population and implications for heart failure prevention: reports from the China Hypertension Survey 2012-15.
心力衰竭各阶段在一般人群中的流行情况及其对心力衰竭预防的影响:来自 2012-2015 年中国高血压调查的报告。
Eur J Prev Cardiol. 2023 Sep 20;30(13):1391-1400. doi: 10.1093/eurjpc/zwad223.
4
Comparison of Machine Learning Algorithms for Predicting Hospital Readmissions and Worsening Heart Failure Events in Patients With Heart Failure With Reduced Ejection Fraction: Modeling Study.射血分数降低的心力衰竭患者再入院及心力衰竭恶化事件预测的机器学习算法比较:建模研究
JMIR Form Res. 2023 Apr 17;7:e41775. doi: 10.2196/41775.
5
Worsening Heart Failure: Nomenclature, Epidemiology, and Future Directions: JACC Review Topic of the Week.心力衰竭恶化:命名、流行病学及未来方向:美国心脏病学会杂志本周综述主题
J Am Coll Cardiol. 2023 Jan 31;81(4):413-424. doi: 10.1016/j.jacc.2022.11.023.
6
Lowering Uric Acid May Improve Prognosis in Patients With Hyperuricemia and Heart Failure With Preserved Ejection Fraction.降低血尿酸水平可能改善伴左室射血分数保留的心力衰竭患者的预后。
J Am Heart Assoc. 2022 Oct 4;11(19):e026301. doi: 10.1161/JAHA.122.026301. Epub 2022 Sep 21.
7
Predicting Mortality in Intensive Care Unit Patients With Heart Failure Using an Interpretable Machine Learning Model: Retrospective Cohort Study.利用可解释机器学习模型预测重症监护病房心力衰竭患者的死亡率:回顾性队列研究。
J Med Internet Res. 2022 Aug 9;24(8):e38082. doi: 10.2196/38082.
8
Analysis of Worsening Heart Failure Events in an Integrated Health Care System.综合医疗体系中心力衰竭恶化事件分析。
J Am Coll Cardiol. 2022 Jul 12;80(2):111-122. doi: 10.1016/j.jacc.2022.04.045.
9
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2022年美国心脏协会/美国心脏病学会/美国心力衰竭学会心力衰竭管理指南:执行摘要:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2022 May 3;145(18):e876-e894. doi: 10.1161/CIR.0000000000001062. Epub 2022 Apr 1.
10
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC.2021 ESC 急性和慢性心力衰竭诊断和治疗指南:由欧洲心脏病学会(ESC)急性和慢性心力衰竭诊断和治疗工作组制定。特别感谢欧洲心脏病学会心力衰竭协会(HFA)的贡献。
Eur J Heart Fail. 2022 Jan;24(1):4-131. doi: 10.1002/ejhf.2333.